Leucomycin A1

• Description :

  Leucomycin A1 is a main component of the leucomycin complex produced by Streptomyces kitasatoensis, Leucomycin A1 is an antibiotic[1].

• UNSPSC :

  12352005

• Target :

  Antibiotic; Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Anti-infection; Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/leucomycin-a1.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O[C@H]([C@H]([C@H](O[C@@]1([H])C[C@@](O)([C@@H](OC(CC(C)C)=O)[C@H](C)O1)C)[C@@H](C)O2)N(C)C)[C@]2([H])O[C@H]3[C@H](C[C@H]([C@H](/C=C/C=C/C[C@@H](C)OC(C[C@@H](O)[C@@H]3OC)=O)O)C)CC=O

• Molecular Formula :

  C40H67NO14

• Molecular Weight :

  785.96

• References & Citations :

  [1]Watanabe T, et al. Studies on leucomycin. V. Isolation of mycaros-4-isovalerate from leucomycin A1. Bulletin of the Chemical Society of Japan, 1961, 34 (9) : 1285-1288.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [16846-34-7]